Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

Hepatology

Volumn 35, Issue 1, 2002, Pages 176-181

  Angelico, Mario ^a   Di Paolo, Daniele ^a   Trinito, Massimo O ^b   Petrolati, Alessandra ^a   Araco, Antonio ^a   Zazza, Settimio ^a   Lionetti, Raffaella ^a   Casciani, Carlo U ^a   Tisone, Giuseppe ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; RECOMBINANT VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; VACCINATION;

EID: 0036139952     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30278     Document Type: Article

References (37)

1. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease
2. Hepatic histologic findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis
3. Liver transplantation in European patients with the hepatitis B surface antigen
4. Hepatitis B virus infection and liver transplantation
5. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: Adequate immunoprophylaxis and delta virus coinfection as the significant determinants of long-term prognosis
6. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: A concise review
7. Hepatitis B virus mutants in liver transplant recipients who are reinfected despite hepatitis B immune globulin prophylaxis
8. Clinical relevance of hepatitis B viral mutations. Concise review
9. Mercury poisoning associated with high dose hepatitis B-immune globulin administration after liver transplantation for chronic hepatitis B
10. Liver transplantation for hepatitis B cirrhosis: Clinical sequelae of passive immunization
11. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin
12. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
13. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation
14. Vaccination of the dialysis patient
15. Hepatitis B vaccination results in 140 liver transplant recipients
16. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease
17. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C
18. Low repeated doses of intradermal hepatitis B vaccine produce protective levels of antibodies in hemodialyzed patients non-responding to usual and double multiple doses
19. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost effectiveness evaluation
20. Appraisal of intradermal immunisation against hepatitis B
21. Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients
22. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination
23. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen
24. Hepatitis B and liver transplantation. Problems and promises
25. Hepatitis B vaccine in medical staff of dialysis units. Efficacy and subtype cross-protection
26. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men
27. Accelerated schedule of hepatitis B vaccination in liver transplant candidates
28. Enhanced immunogenicity in ice with hepatitis B vaccine complexed yo human hepatitis B immunoglobulin
29. Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes
30. Lamivudine treatment can restore T-cell responsiveness in chronic hepatitis B
31. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
32. Prevention of acute and chronic liver disease through immunization. Hepatitis B and beyond
33. Vaccination against hepatitis A and B in chronic liver disease
34. Vaccination of patients with liver disease. Who, when and how
35. Failure of hepatitis B vaccination in liver transplant recipients: Results of a prospective trial
36. Thymopentin administration and increase of sero-conversion after B-hepatitis vaccine in diabetic patients
37. Response to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality